glp 1 lilly FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic GLP-1 GOSSIP - xoxo ,

Emerging 2025 research suggests semaglutide (the drug in Ozempic and Wegovy) is associated with lower RA disease activity, less pain, and improved joint outcomes especially in patients who also carry excess weight

For children aged 114 years, the AIs increase with age from 1.5 to 3.5 g/day

They also restricted their analysis to studies reporting at least 3kg on-treatment average weight loss

While large clinical trials in type 1 diabetes showed that metformin had little effect on A1C and body weight, other research has shown that the same group does benefit from metformin, particularly for addressing insulin resistance

These conditions result in the overproduction of AGEs, accumulation of pro-inflammatory and pro-fibrotic factors, and free fatty acid oxidation